These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10599142)

  • 1. [Correction of diabetic neuropathies using aldose reductase inhibitors and pikamilon].
    Kuchmerovskaia TM; Parkhomets PK; Donchenko GV; Obrosova IG; Klimenko AP; Kuchmerovskiĭ NA; Pakirbaeva LV; Efimov AS
    Vopr Med Khim; 1998; 44(6):559-64. PubMed ID: 10599142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of aldose reductase inhibitors in the development of peripheral neuropathy in experimental diabetes].
    Kuchmerovskaia TM; Donchenko GV; Klimenko AP; Chichkovskaia GV; Pakirbaeva LV; Kozitskiĭ ZIa; Efimov AS
    Ukr Biokhim Zh (1978); 1997; 69(3):77-82. PubMed ID: 9505366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
    Hara T; Nakamura J; Koh N; Sakakibara F; Hamada Y; Sasaki H; Naruse K; Nakashima E; Takeuchi N; Inukai S
    J Lab Clin Med; 1995 Dec; 126(6):541-7. PubMed ID: 7490513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
    Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of nicotinamide on the uptake and release of serotonin and GABA by cerebral cortex synaptosomes in rats with diabetes induced by streptozotocin].
    Donchenko GV; Kuchmerovskaia TM; Parkhomets PK; Obrosova IG; Klimenko AP; Efimov AS
    Ukr Biokhim Zh (1978); 1995; 67(1):105-11. PubMed ID: 8588246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldose reductase inhibitors.
    Kirchain WR; Rendell MS
    Pharmacotherapy; 1990; 10(5):326-36. PubMed ID: 2122421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
    Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS
    Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats.
    Shimoshige Y; Ikuma K; Yamamoto T; Takakura S; Kawamura I; Seki J; Mutoh S; Goto T
    Metabolism; 2000 Nov; 49(11):1395-9. PubMed ID: 11092500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
    Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
    Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1H-NMR analysis of nerve edema in the streptozotocin-induced diabetic rat.
    Suzuki E; Yasuda K; Yasuda K; Miyazaki S; Takeda N; Inouye H; Omawari N; Miura K
    J Lab Clin Med; 1994 Nov; 124(5):627-37. PubMed ID: 7964120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats.
    Nakamura J; Koh N; Sakakibara F; Hamada Y; Hara T; Sasaki H; Chaya S; Komori T; Nakashima E; Naruse K; Kato K; Takeuchi N; Kasuya Y; Hotta N
    J Pharmacol Exp Ther; 1998 Dec; 287(3):897-902. PubMed ID: 9864270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of structurally diverse aldose reductase inhibitors on experimental periodontitis in rats.
    Kador PF; O'Meara JD; Blessing K; Marx DB; Reinhardt RA
    J Periodontol; 2011 Jun; 82(6):926-33. PubMed ID: 21189083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic neuropathies. Metabolism of sorbitol in sciatic nerve tissue in streptozotocin diabetes].
    Kryvko IuIa; Kozyts'kyĭ ZIa; Serhiienko OO; Kuchmerovs'ka TM; Velykyĭ MM
    Ukr Biokhim Zh (1999); 2001; 73(5):69-74. PubMed ID: 12035507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldose reductase inhibitor ONO-2235 restores the alterations of bladder nerve growth factor and neurotrophin receptor p75 genetic expression in streptozotocin induced diabetic rats.
    Tong YC; Cheng JT
    J Urol; 2007 Nov; 178(5):2203-7. PubMed ID: 17870109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of diabetic neuropathy--do hyperglycemia and aldose reductase inhibitors affect neuroactive steroid formation in the rat sciatic nerves?
    Colciago A; Negri-Cesi P; Celotti F
    Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):22-6. PubMed ID: 11835121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA; Cameron NE; Hohman TC
    J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
    Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal effects of two aldose reductase inhibitors, AL-1576 and AL-4114, after subacute topical-ocular dosing on xenobiotic biotransformation in rabbits.
    Sastry SG; Sanders RA; Veltman JC; Watkins JB
    Drug Metab Dispos; 1995 Oct; 23(10):1094-8. PubMed ID: 8654197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of sorbitol pathway and treatment effect of aldose reductase inhibitor ONO2235 in the up-regulation of cardiac M2-muscarinic receptors in streptozotocin-induced diabetic rats.
    Liu TP; Juang SW; Cheng JT; Tong YC
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):131-5. PubMed ID: 15936525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.